Evidence map›Paper›PMID 40089506›Full record

ArticleNature communications2025

Optically tunable catalytic cancer therapy using enzyme-like chiral plasmonic nanoparticles.

Haeun Kang, Subin Yu, Ryeong Myeong Kim, Youngbi Kim, Sang Chul Shin, Dohyub Jang, Jeong Hyun Han, Sugyeong Hong, Eunice EunKyeong Kim, Sun Hee Kim and 6 more

Abstract read
In one paragraph

Article in Nature communications, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

Haeun Kang *Department of Chemistry and Nanoscience, Ewha Womans University, Seoul, Republic of Korea.ORCID http://orcid.org/0000-0002-8923-0528
Subin Yu *Department of Chemistry and Nanoscience, Ewha Womans University, Seoul, Republic of Korea.ORCID http://orcid.org/0000-0002-8791-2277
Ryeong Myeong Kim *Department of Materials Science and Engineering, Seoul National University, Seoul, Republic of Korea.
Youngbi KimDepartment of Chemical Engineering, Pohang University of Science and Technology, Pohang, Gyeongbuk, Republic of Korea.
Sang Chul ShinTechnological Convergence Center, Research Resources Division, Korea Institute of Science and Technology, Seongbuk-gu, Seoul, Republic of Korea.ORCID http://orcid.org/0000-0003-0156-680X
Dohyub JangDepartment of Biomicrosystem Technology, Korea University, Seoul, Republic of Korea.
Jeong Hyun HanDepartment of Materials Science and Engineering, Seoul National University, Seoul, Republic of Korea.
Sugyeong HongWestern Seoul Center, Korea Basic Science Institute, Seoul, Republic of Korea.
Eunice EunKyeong KimBiomedical Research Institute, Korea Institute of Science and Technology, Hwarang 14-gil 5, Seongbuk-gu, Seoul, Republic of Korea.ORCID http://orcid.org/0000-0002-7707-8055
Sun Hee KimWestern Seoul Center, Korea Basic Science Institute, Seoul, Republic of Korea.ORCID http://orcid.org/0000-0001-6557-1996
Dong June AhnDepartment of Biomicrosystem Technology, Korea University, Seoul, Republic of Korea.ORCID http://orcid.org/0000-0001-5205-9168
Jeong Woo HanDepartment of Materials Science and Engineering, Seoul National University, Seoul, Republic of Korea. jwhan98@snu.ac.kr.ORCID http://orcid.org/0000-0001-5676-5844
Sehoon KimKU-KIST Graduate School of Converging Science and Technology, Korea University, Seoul, Republic of Korea. sehoonkim@kist.re.kr.ORCID http://orcid.org/0000-0002-8074-1006
Ki Tae NamDepartment of Materials Science and Engineering, Seoul National University, Seoul, Republic of Korea. nkitae@snu.ac.kr.ORCID http://orcid.org/0000-0001-6353-8877
Luke P LeeHarvard Medical School, Harvard University; Department of Medicine, Brigham and Women's Hospital, Boston, MA, USA. lplee@bwh.harvard.edu.ORCID http://orcid.org/0000-0002-1436-4054
Dong Ha KimDepartment of Chemistry and Nanoscience, Ewha Womans University, Seoul, Republic of Korea. dhkim@ewha.ac.kr.ORCID http://orcid.org/0000-0003-0444-0479

Funding

Korea Basic Science Institute (KBSI) 2020R1A6C101B194Korea Institute of Science and Technology (KIST) 2E33132National Research Foundation of Korea (NRF) 2020R1A2C3003958National Research Foundation of Korea (NRF) 2021R1A6A1A10039823National Research Foundation of Korea (NRF) RS-2024-00407093
6 · The paper itself

Abstract

Cascade enzymatic reactions in living organisms are fundamental reaction mechanisms in coordinating various complex biochemical processes such as metabolism, signal transduction, and gene regulation. Many studies have attempted to mimic cascade reactions using nanoparticles with enzyme-like activity; however, precisely tuning each reaction within complex networks to enhance the catalytic activity remains challenging. Here, we present enzyme-like chiral plasmonic nanoparticles for optically tunable catalytic cancer therapy. We create chiral plasmonic nanoparticles with glucose oxidase (GOD) and peroxidase (POD) activities, followed by introducing circularly polarized light (CPL). By sequentially activating GOD and POD reactions with right-handed CPL (RC) followed by left-handed CPL (LC), we achieve 1.25- and 1.9-fold enhanced catalytic performance (overall 1.3 times enhancement) compared to non-controlled cascade reactions by creating an optimal acidic environment for the subsequent reaction. Moreover, the D-Au nanoparticle shows a 2-fold higher binding selectivity to D-glucose substrates, attributed to chirality matching. In both cell studies and male mouse models, sequentially irradiated groups (RC followed by LC) exhibit the highest radical generation and the most efficient treatment outcomes compared to the other systems under different irradiation conditions. We believe that our system holds strong potential for medical applications, suggesting a promising platform for catalytic therapy.

Indexed as

Metal NanoparticlesNeoplasmsAnimalsCatalysisCell Line, TumorGlucoseGlucose OxidaseGoldHumansMaleMicePeroxidaseGlucoseGlucose OxidaseGoldPeroxidase

Identifiers

PMID40089506
PMCPMC11910523

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.